Download

Download Full Text (293 KB)

Description

Racial disparities in access to health care have been described previously. However, limited data exist on how these disparities manifest in end stage heart failure patients at the time of evaluation for heart transplant or LVAD. The objective of this study is to evaluate racial disparities in the clinical characteristics and outcomes of patients referred for AHF therapy evaluation.

Racial disparities in access to health care have been described previously. However, limited data exist on how these disparities manifest in end stage heart failure patients at the time of evaluation for heart transplant or LVAD. The objective of this study is to evaluate racial disparities in the clinical characteristics and outcomes of patients referred for AHF therapy evaluation.

All patients evaluated for AHF therapies at Corewell Health West between January 2009 and September 2024 were included in this study. Patients were categorized by race into 3 groups (White, Black, other race). Epidemiologic, clinical, and outcome data were collected and compared across groups.

A total of 1199 patients were included in this study. Of these, 927 (77.3%) were White, 154 (12.8%) were Black, and 118 (9.9%) were other race. Significant differences were observed across groups (Table 1). In summary, White patients were older, less likely to be female, had a higher income level, and had more ischemic cardiomyopathy. Black and other race patients were more likely to reside in urban areas, have lower socioeconomic status, and less likely to be accepted for AHF therapies.

Publication Date

5-8-2026

Disciplines

Cardiology

Comments

2026 Research Day Corewell Health West, Grand Rapids, MI, May 8, 2026. Abstract 2019

Race-Based Disparities in Advanced Heart Failure Evaluation and Outcomes

Share

COinS